PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
IOVA vs. IDYA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Performance

IOVA vs. IDYA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Iovance Biotherapeutics, Inc. (IOVA) and IDEAYA Biosciences, Inc. (IDYA). The values are adjusted to include any dividend payments, if applicable.

-40.00%-30.00%-20.00%-10.00%0.00%10.00%20.00%JuneJulyAugustSeptemberOctoberNovember
-18.55%
-35.04%
IOVA
IDYA

Returns By Period

In the year-to-date period, IOVA achieves a 3.69% return, which is significantly higher than IDYA's -26.39% return.


IOVA

YTD

3.69%

1M

-17.68%

6M

-18.55%

1Y

66.93%

5Y (annualized)

-18.22%

10Y (annualized)

3.82%

IDYA

YTD

-26.39%

1M

-14.24%

6M

-35.04%

1Y

-13.76%

5Y (annualized)

31.15%

10Y (annualized)

N/A

Fundamentals


IOVAIDYA
Market Cap$2.57B$2.26B
EPS-$1.52-$2.33
Total Revenue (TTM)$90.86M$3.92M
Gross Profit (TTM)-$12.33M$720.00K
EBITDA (TTM)-$396.36M-$223.50M

Key characteristics


IOVAIDYA
Sharpe Ratio1.00-0.27
Sortino Ratio2.03-0.09
Omega Ratio1.230.99
Calmar Ratio0.95-0.28
Martin Ratio2.59-0.65
Ulcer Index35.41%19.20%
Daily Std Dev90.84%46.11%
Max Drawdown-99.37%-74.64%
Current Drawdown-94.70%-44.43%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Correlation

-0.50.00.51.00.3

The correlation between IOVA and IDYA is 0.31, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Risk-Adjusted Performance

IOVA vs. IDYA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Iovance Biotherapeutics, Inc. (IOVA) and IDEAYA Biosciences, Inc. (IDYA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for IOVA, currently valued at 1.00, compared to the broader market-4.00-2.000.002.004.001.00-0.27
The chart of Sortino ratio for IOVA, currently valued at 2.03, compared to the broader market-4.00-2.000.002.004.002.03-0.09
The chart of Omega ratio for IOVA, currently valued at 1.23, compared to the broader market0.501.001.502.001.230.99
The chart of Calmar ratio for IOVA, currently valued at 1.01, compared to the broader market0.002.004.006.001.01-0.28
The chart of Martin ratio for IOVA, currently valued at 2.59, compared to the broader market-10.000.0010.0020.0030.002.59-0.65
IOVA
IDYA

The current IOVA Sharpe Ratio is 1.00, which is higher than the IDYA Sharpe Ratio of -0.27. The chart below compares the historical Sharpe Ratios of IOVA and IDYA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Rolling 12-month Sharpe Ratio0.000.501.001.502.00JuneJulyAugustSeptemberOctoberNovember
1.00
-0.27
IOVA
IDYA

Dividends

IOVA vs. IDYA - Dividend Comparison

Neither IOVA nor IDYA has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

IOVA vs. IDYA - Drawdown Comparison

The maximum IOVA drawdown since its inception was -99.37%, which is greater than IDYA's maximum drawdown of -74.64%. Use the drawdown chart below to compare losses from any high point for IOVA and IDYA. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-83.97%
-44.43%
IOVA
IDYA

Volatility

IOVA vs. IDYA - Volatility Comparison

Iovance Biotherapeutics, Inc. (IOVA) has a higher volatility of 24.91% compared to IDEAYA Biosciences, Inc. (IDYA) at 15.15%. This indicates that IOVA's price experiences larger fluctuations and is considered to be riskier than IDYA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%JuneJulyAugustSeptemberOctoberNovember
24.91%
15.15%
IOVA
IDYA

Financials

IOVA vs. IDYA - Financials Comparison

This section allows you to compare key financial metrics between Iovance Biotherapeutics, Inc. and IDEAYA Biosciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items